Treatment-free survival after first-line therapies for metastatic renal cell carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) analysis.

被引：0
|
作者：
Gupta, Mehul
Wells, Connor
Regan, Meredith M.
Xie, Wanling
Navani, Vishal
Saliby, Renee Maria
Basappa, Naveen S.
Donskov, Frede
Yuasa, Takeshi
Takemura, Kosuke null
Kollmannsberger, Christian K.
Crumbaker, Megan
Lalani, Aly-Khan A.
Powles, Thomas
Pal, Sumanta Kumar
Mckay, Rana R.
Lee, Jae-Lyun
Kanesvaran, Ravindran
Choueiri, Toni K.
Heng, Daniel Yick Chin
机构：
[1] Univ Calgary, Arnie Charbonneau Canc Res Inst, Calgary, AB, Canada
[2] BC Canc Agcy, Vancouver, BC, Canada
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA
[5] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[6] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
[7] Univ Hosp, Aarhus, Denmark
[8] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[9] British Columbia Canc Agcy, Vancouver, BC, Canada
[10] St Vincents Hosp, Sydney, NSW, Australia
[11] McMaster Univ, Juravinski Canc Ctr, Dept Oncol, Hamilton, ON, Canada
[12] Barts Canc Inst, London, England
[13] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut, Duarte, CA USA
[14] Univ Calif San Diego, San Diego, CA USA
[15] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[16] Natl Canc Ctr, Singapore, Singapore
[17] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
281-5277-5597; 283-2494-9200; 261-566-9263; 130-540-543-4790; 130-540-543-12277; 261-492-3532-2370-2813-7645; 261-566-11347; 7; 6; 5; 3; 2; 137; 4; 2434; 171; 319; 1;
D O I：
10.1200/JCO.2024.42.4_suppl.390
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [11] Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Graham, Jeffrey
    Wells, Connor
    Donskov, Frede
    Lee, Jae-Lyun
    Fraccon, Anna Paola
    Pasini, Felice
    Porta, Camillo
    Bowman, I. Alex
    Bjarnason, Georg A.
    Ernst, D. Scott
    Rha, Sun Young
    Beuselinck, Benoit
    Hansen, Aaron Richard
    North, Scott A.
    Kollmannsberger, Christian K.
    Wood, Lori
    Vaishampayan, Ulka N.
    Pal, Sumanta K.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [12] Re: First-Line Sunitinib versus Pazopanib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Laguna, M. Pilar
    JOURNAL OF UROLOGY, 2017, 197 (03): : 603 - 603
  • [13] First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium
    Dudani, Shaan
    Graham, Jeffrey
    Wells, J. Connor
    Bakouny, Ziad
    Pal, Sumanta K.
    Dizman, Nazli
    Donskov, Frede
    Porta, Camillo
    de Velasco, Guillermo
    Hansen, Aaron
    Iafolla, Marco
    Beuselinck, Benoit
    Vaishampayan, Ulka N.
    Woodk, Lori A.
    Liow, Elizabeth
    Yan, Flora
    Yuasa, Takeshi
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY, 2019, 76 (06) : 861 - 867
  • [14] The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model as a prognostic tool in metastatic renal cell carcinoma (mRCC) patients previously treated with first-line targeted therapy (TT)
    Ko, Jenny J.
    Xie, Wanling
    Heng, Daniel Yick Chin
    Kroeger, Nils
    Lee, Jae-Lyun
    Rini, Brian I.
    Knox, Jennifer J.
    Bjarnason, Georg A.
    Harshman, Lauren Christine
    Pal, Sumanta Kumar
    Yuasa, Takeshi
    Smoragiewicz, Martin
    Donskov, Frede
    Bamias, Aristotelis
    Wood, Lori
    Ernst, D. Scott
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Rha, Sun Young
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [15] First-line (1L) immuno-oncology (10) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Dudani, Shaan
    Graham, Jeffrey
    Wells, Connor
    Pal, Sumanta K.
    Dizman, Nazli
    Donskov, Frede
    Bjarnason, Georg A.
    Hansen, Aaron Richard
    Iafolla, Marco Adelmo James
    Vaishampayan, Ulka N.
    Porta, Camillo
    Beuselinck, Benoit
    Yan, Flora
    Wood, Lori
    Liow, Elizabeth Chien Hern
    Kollmannsberger, Christian K.
    Yuasa, Takeshi
    Zhang, Chiyuan A.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [16] First-Line Mammalian Target of Rapamycin Inhibition in Metastatic Renal Cell Carcinoma: An Analysis of Practice Patterns From the International Metastatic Renal Cell Carcinoma Database Consortium
    Harshman, Lauren C.
    Kroeger, Nils
    Rha, Sun Young
    Donskov, Frede
    Wood, Lori
    Tantravahi, Srinivas K.
    Vaishampayan, Ulka
    Rini, Brian I.
    Knox, Jennifer
    North, Scott
    Ernst, Scott
    Yuasa, Takeshi
    Srinivas, Sandy
    Pal, Sumanta
    Heng, Daniel Y.
    Choueiri, Toni K.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (05) : 335 - 340
  • [17] Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma treated with first-line combination immunotherapies: Results from the International metastatic renal cell carcinoma database consortium (IMDC)
    Takemura, K.
    Yuasa, T.
    Lemelin, A.
    Ferrier, E.
    Wells, J. C.
    Saad, E.
    Saliby, R. M.
    Basappa, N. S.
    Wood, L. A.
    Jude, E.
    Pal, S. K.
    Donskov, F.
    Beuselinck, B.
    Szabados, B. E.
    Powles, T. B.
    Mckay, R. R.
    Gebrael, G.
    Agarwal, N.
    Choueiri, T. K.
    Heng, D. Y. C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1558 - S1559
  • [18] Updated outcomes of patients with metastatic non-clear cell renal cell carcinoma (mnccRCC) treated with first-line (1L) therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Takemura, Kosuke
    Graham, Jeffrey
    Maj, David
    Zarba, Martin
    Wells, Connor
    Chehade, Razane El Hajj
    Eid, Marc
    Saad, Eddy
    Saliby, Renee Maria
    Lee, Jae Lyun
    Donskov, Frede
    Beuselinck, Benoit
    Jude, Evon
    McKay, Rana R.
    Basappa, Naveen S.
    Pal, Sumanta Kumar
    Porta, Camillo
    Agarwal, Neeraj
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [19] Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium EDITORIAL COMMENT
    Singla, Nirmish
    JOURNAL OF UROLOGY, 2023, 209 (04): : 709 - 709
  • [20] First line sunitinib versus pazopanib in metastatic renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium
    Morales, Jose Manuel Ruiz
    Wells, J. Connor
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae Lyun
    Knox, Jennifer J.
    Beuselinck, Benoit
    Vasihampayan, Ulka
    Brugarolas, James
    Broom, Reuben
    Koutsoukos, Konstantinos
    Yuasa, Takeshi
    Srinivas, Sandy
    Ernst, D. Scott
    Pezaro, Carmel
    Wood, Lori A.
    Kollmannsberger, Christian
    Rini, Brian I.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    BJU INTERNATIONAL, 2015, 116 : 20 - 20
12345